ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAJ SAMTANI M.D.

Cardiovascular Disease

1,074

$55.4K

79
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $84

SABAPATHIPPILLAI KULATHUNGAM M.D.

Cardiovascular Disease

820

$35.6K

123
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $84

MICHAEL SCHWARTZ M.D.

Cardiovascular Disease

735

$34.3K

82
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$47
Average prescription price

Avg: $84

BRENT COLE M.D.

Cardiovascular Disease

2,276

$165K

202
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $84

MIRIAM COHEN M.D.

Cardiovascular Disease

1,304

$101K

198
177 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $84

ETHAN HASKEL M.D.

Cardiovascular Disease

1,792

$130K

296
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$72
Average prescription price

Avg: $84

YANJALAGERE RAMAIAH M.D.

Cardiovascular Disease

900

$31.3K

30
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $84

STEPHEN PLANTHOLT M.D.

Cardiovascular Disease

3,697

$235K

433
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $84

LOUIS ESSANDOH MD

Cardiovascular Disease

1,248

$92.6K

142
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $84

RAYMON NELSON MD

Cardiovascular Disease

5,269

$674K

191
147 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$128
Average prescription price

Avg: $84

BRUCE ZINSMEISTER M.D.

Cardiovascular Disease

1,869

$194K

191
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$104
Average prescription price

Avg: $84

JOHN MARRA M.D.

Cardiovascular Disease

3,488

$228K

262
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $84

THOMAS KO M.D.

Cardiovascular Disease

2,562

$142K

307
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $84

CHRYSOLOGUE GAKUBA M.D.

Cardiovascular Disease

16,870

$1.39M

321
310 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $84

ZALMAN KAHN M.D.

Cardiovascular Disease

2,224

$219K

265
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$98
Average prescription price

Avg: $84

DAVID GOORAY MD

Cardiovascular Disease

4,033

$427K

206
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $84

ANIL SHAH

Cardiovascular Disease

1,918

$124K

242
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $84

WILLIAM HOOD M.D.

Cardiovascular Disease

951

$63.1K

211
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $84

ERNESTO AFRICANO M.D.

Cardiovascular Disease

8,042

$399K

357
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $84

DONALD WOOD M.D.

Cardiovascular Disease

6,606

$452K

802
712 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $84

HAFEEZ SYED

Cardiovascular Disease

2,691

$285K

195
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$106
Average prescription price

Avg: $84

TUNG DAO M.D.

Cardiovascular Disease

1,213

$106K

358
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $84

SHUBIR SOFAT MD

Cardiovascular Disease

566

$38.6K

114
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $84

ALLEN NIMETZ M.D.

Cardiovascular Disease

1,985

$262K

177
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 28%

$132
Average prescription price

Avg: $84

HERMAN SEGAL MD

Cardiovascular Disease

1,181

$91.9K

199
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $84

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank